These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 32685019)

  • 1. Inhibition of Glutaredoxin 5 predisposes Cisplatin-resistant Head and Neck Cancer Cells to Ferroptosis.
    Lee J; You JH; Shin D; Roh JL
    Theranostics; 2020; 10(17):7775-7786. PubMed ID: 32685019
    [No Abstract]   [Full Text] [Related]  

  • 2. Dihydrolipoamide dehydrogenase regulates cystine deprivation-induced ferroptosis in head and neck cancer.
    Shin D; Lee J; You JH; Kim D; Roh JL
    Redox Biol; 2020 Feb; 30():101418. PubMed ID: 31931284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of ferroptotic cell death for overcoming cisplatin resistance of head and neck cancer.
    Roh JL; Kim EH; Jang HJ; Park JY; Shin D
    Cancer Lett; 2016 Oct; 381(1):96-103. PubMed ID: 27477897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nrf2 inhibition reverses the resistance of cisplatin-resistant head and neck cancer cells to artesunate-induced ferroptosis.
    Roh JL; Kim EH; Jang H; Shin D
    Redox Biol; 2017 Apr; 11():254-262. PubMed ID: 28012440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CISD2 inhibition overcomes resistance to sulfasalazine-induced ferroptotic cell death in head and neck cancer.
    Kim EH; Shin D; Lee J; Jung AR; Roh JL
    Cancer Lett; 2018 Sep; 432():180-190. PubMed ID: 29928961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nrf2 inhibition reverses resistance to GPX4 inhibitor-induced ferroptosis in head and neck cancer.
    Shin D; Kim EH; Lee J; Roh JL
    Free Radic Biol Med; 2018 Dec; 129():454-462. PubMed ID: 30339884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of mitochondrial oxidation by PDK2 inhibition reverses cisplatin resistance in head and neck cancer.
    Roh JL; Park JY; Kim EH; Jang HJ; Kwon M
    Cancer Lett; 2016 Feb; 371(1):20-9. PubMed ID: 26607904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitochondrial pyruvate carrier 1 regulates ferroptosis in drug-tolerant persister head and neck cancer cells via epithelial-mesenchymal transition.
    You JH; Lee J; Roh JL
    Cancer Lett; 2021 Jun; 507():40-54. PubMed ID: 33741422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of AEBP1 predisposes cisplatin-resistant oral cancer cells to ferroptosis.
    Zhou Q; Wang X; Zhang Y; Wang L; Chen Z
    BMC Oral Health; 2022 Nov; 22(1):478. PubMed ID: 36352396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PGRMC1-dependent lipophagy promotes ferroptosis in paclitaxel-tolerant persister cancer cells.
    You JH; Lee J; Roh JL
    J Exp Clin Cancer Res; 2021 Nov; 40(1):350. PubMed ID: 34749765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DHA exhibits synergistic therapeutic efficacy with cisplatin to induce ferroptosis in pancreatic ductal adenocarcinoma via modulation of iron metabolism.
    Du J; Wang X; Li Y; Ren X; Zhou Y; Hu W; Zhou C; Jing Q; Yang C; Wang L; Li H; Fang L; Zhou Y; Tong X; Wang Y
    Cell Death Dis; 2021 Jul; 12(7):705. PubMed ID: 34262021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Salvia miltiorrhiza Bge. processed with porcine cardiac blood inhibited GLRX5-mediated ferroptosis alleviating cerebral ischemia-reperfusion injury.
    Zhou S; Wang Z; Wang T; Peng C; Zhang J; Liu C; Xu J; Zhang Y; Zhang L; Luo L; Yan X
    Phytomedicine; 2024 Jul; 129():155622. PubMed ID: 38677272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting acid ceramidase sensitises head and neck cancer to cisplatin.
    Roh JL; Park JY; Kim EH; Jang HJ
    Eur J Cancer; 2016 Jan; 52():163-72. PubMed ID: 26687835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic reprogramming of epithelial-mesenchymal transition promotes ferroptosis of head and neck cancer.
    Lee J; You JH; Kim MS; Roh JL
    Redox Biol; 2020 Oct; 37():101697. PubMed ID: 32896720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Poly(rC)-binding protein 1 represses ferritinophagy-mediated ferroptosis in head and neck cancer.
    Lee J; You JH; Roh JL
    Redox Biol; 2022 May; 51():102276. PubMed ID: 35290903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Promotion of ferroptosis in head and neck cancer with divalent metal transporter 1 inhibition or salinomycin.
    Lee J; Roh JL
    Hum Cell; 2023 May; 36(3):1090-1098. PubMed ID: 36890422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hederagenin Induces Apoptosis in Cisplatin-Resistant Head and Neck Cancer Cells by Inhibiting the Nrf2-ARE Antioxidant Pathway.
    Kim EH; Baek S; Shin D; Lee J; Roh JL
    Oxid Med Cell Longev; 2017; 2017():5498908. PubMed ID: 29456786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting Nrf2 with wogonin overcomes cisplatin resistance in head and neck cancer.
    Kim EH; Jang H; Shin D; Baek SH; Roh JL
    Apoptosis; 2016 Nov; 21(11):1265-1278. PubMed ID: 27544755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Novel Polyphenol Conjugate Sensitizes Cisplatin-Resistant Head and Neck Cancer Cells to Cisplatin via Nrf2 Inhibition.
    Kim EH; Jang H; Roh JL
    Mol Cancer Ther; 2016 Nov; 15(11):2620-2629. PubMed ID: 27550943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aspirin plus sorafenib potentiates cisplatin cytotoxicity in resistant head and neck cancer cells through xCT inhibition.
    Roh JL; Kim EH; Jang H; Shin D
    Free Radic Biol Med; 2017 Mar; 104():1-9. PubMed ID: 28057599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.